Clinical Trials
8 trialsNCT07623187 2026-06-03
EVICTION 3
Ipsen
Phase 2/3 Not yet recruiting
NCT07583888 2026-05-14
VABu Conditioning in Elderly AML HSCT
The First Affiliated Hospital of Soochow University
Phase 2/3 Recruiting
NCT07581002 2026-05-12
REVIVAL
AbbVie
Phase 2/3 Not yet recruiting
NCT04217278 2026-05-05
COSI
University of Birmingham
Phase 2/3 Active not recruiting
NCT04256317 2026-04-30
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Phase 2/3 Recruiting
NCT06788756 2026-04-29
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
Moleculin Biotech, Inc.
Phase 2/3 Recruiting
NCT07537257 2026-04-17
VEN+IDAC vs IDAC in AML
Guangdong Second Provincial General Hospital
Phase 2/3 Enrolling by invitation
NCT07255872 2026-03-05
A Study of BL-M11D1 in Combination With Cytarabine + Daunorubicin or Venetoclax + Azacitidine in Patients With Acute Myeloid Leukemia
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2/3 Not yet recruiting